Literature DB >> 33530447

Genome-Wide DNA Methylation Analysis of a Cohort of 41 Patients Affected by Oculo-Auriculo-Vertebral Spectrum (OAVS).

Valentina Guida1, Luciano Calzari2, Maria Teresa Fadda3, Francesca Piceci-Sparascio1,4, Maria Cristina Digilio5, Laura Bernardini1, Francesco Brancati6,7, Teresa Mattina8, Daniela Melis9, Francesca Forzano10, Silvana Briuglia11, Tommaso Mazza12, Sebastiano Bianca13, Enza Maria Valente14,15, Leila Bagherjad Salehi16, Paolo Prontera17, Mario Pagnoni3, Romano Tenconi18, Bruno Dallapiccola5, Giorgio Iannetti3, Luigi Corsaro19, Alessandro De Luca1, Davide Gentilini2,19.   

Abstract

Oculo-auriculo-vertebral-spectrum (OAVS; OMIM 164210) is a rare disorder originating from abnormal development of the first and second branchial arch. The clinical phenotype is extremely heterogeneous with ear anomalies, hemifacial microsomia, ocular defects, and vertebral malformations being the main features. MYT1, AMIGO2, and ZYG11B gene variants were reported in a few OAVS patients, but the etiology remains largely unknown. A multifactorial origin has been proposed, including the involvement of environmental and epigenetic mechanisms. To identify the epigenetic mechanisms contributing to OAVS, we evaluated the DNA-methylation profiles of 41 OAVS unrelated affected individuals by using a genome-wide microarray-based methylation approach. The analysis was first carried out comparing OAVS patients with controls at the group level. It revealed a moderate epigenetic variation in a large number of genes implicated in basic chromatin dynamics such as DNA packaging and protein-DNA organization. The alternative analysis in individual profiles based on the searching for Stochastic Epigenetic Variants (SEV) identified an increased number of SEVs in OAVS patients compared to controls. Although no recurrent deregulated enriched regions were found, isolated patients harboring suggestive epigenetic deregulations were identified. The recognition of a different DNA methylation pattern in the OAVS cohort and the identification of isolated patients with suggestive epigenetic variations provide consistent evidence for the contribution of epigenetic mechanisms to the etiology of this complex and heterogeneous disorder.

Entities:  

Keywords:  DNA-methylation; OAVS; genome-wide; infinium human methylation 450K beadchip; oculo-auriculo-vertebral spectrum; retinoic acid

Mesh:

Year:  2021        PMID: 33530447      PMCID: PMC7866060          DOI: 10.3390/ijms22031190

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  76 in total

1.  Neural crest cells provide species-specific patterning information in the developing branchial skeleton.

Authors:  Abigail S Tucker; Andrew Lumsden
Journal:  Evol Dev       Date:  2004 Jan-Feb       Impact factor: 1.930

Review 2.  Activating and inactivating mutations in the human GNAS1 gene.

Authors:  M A Aldred; R C Trembath
Journal:  Hum Mutat       Date:  2000-09       Impact factor: 4.878

3.  Array-CGH analysis of a cohort of 86 patients with oculoauriculovertebral spectrum.

Authors:  Caroline Rooryck; Noui Souakri; Dorothée Cailley; Julie Bouron; Cyril Goizet; Marie-Ange Delrue; Sandrine Marlin; Feclad Didier Lacombe; Benoît Arveiler
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

4.  Efficient cloning of cDNAs of retinoic acid-responsive genes in P19 embryonal carcinoma cells and characterization of a novel mouse gene, Stra1 (mouse LERK-2/Eplg2).

Authors:  P Bouillet; M Oulad-Abdelghani; S Vicaire; J M Garnier; B Schuhbaur; P Dollé; P Chambon
Journal:  Dev Biol       Date:  1995-08       Impact factor: 3.582

5.  Further evidence for a relationship between the 5p15 chromosome region and the oculoauriculovertebral anomaly.

Authors:  Sirpa Ala-Mello; Linda Siggberg; Sakari Knuutila; Harriet von Koskull; Mervi Taskinen; Maarit Peippo
Journal:  Am J Med Genet A       Date:  2008-10-01       Impact factor: 2.802

6.  Dental and craniofacial features associated with GNAS loss of function mutations.

Authors:  Elvire Le Norcy; Camille Reggio-Paquet; Marc de Kerdanet; Brigitte Mignot; Anya Rothenbuhler; Catherine Chaussain; Agnès Linglart
Journal:  Eur J Orthod       Date:  2020-11-03       Impact factor: 3.075

7.  Social adversity and epigenetic aging: a multi-cohort study on socioeconomic differences in peripheral blood DNA methylation.

Authors:  Giovanni Fiorito; Silvia Polidoro; Pierre-Antoine Dugué; Mika Kivimaki; Erica Ponzi; Giuseppe Matullo; Simonetta Guarrera; Manuela B Assumma; Panagiotis Georgiadis; Soterios A Kyrtopoulos; Vittorio Krogh; Domenico Palli; Salvatore Panico; Carlotta Sacerdote; Rosario Tumino; Marc Chadeau-Hyam; Silvia Stringhini; Gianluca Severi; Allison M Hodge; Graham G Giles; Riccardo Marioni; Richard Karlsson Linnér; Aisling M O'Halloran; Rose A Kenny; Richard Layte; Laura Baglietto; Oliver Robinson; Cathal McCrory; Roger L Milne; Paolo Vineis
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

8.  Epigenome Wide Association and Stochastic Epigenetic Mutation Analysis on Cord Blood of Preterm Birth.

Authors:  Elena Spada; Luciano Calzari; Luigi Corsaro; Teresa Fazia; Monica Mencarelli; Anna Maria Di Blasio; Luisa Bernardinelli; Giulia Zangheri; Michele Vignali; Davide Gentilini
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

9.  The role of Hoxa-3 in mouse thymus and thyroid development.

Authors:  N R Manley; M R Capecchi
Journal:  Development       Date:  1995-07       Impact factor: 6.868

10.  Capturing heterogeneity in gene expression studies by surrogate variable analysis.

Authors:  Jeffrey T Leek; John D Storey
Journal:  PLoS Genet       Date:  2007-08-01       Impact factor: 5.917

View more
  1 in total

1.  Stochastic epigenetic mutations as possible explanation for phenotypical discordance among twins with congenital hypothyroidism.

Authors:  D Gentilini; M Muzza; T de Filippis; M C Vigone; G Weber; L Calzari; A Cassio; M Di Frenna; M Bartolucci; E S Grassi; E Carbone; A Olivieri; L Persani
Journal:  J Endocrinol Invest       Date:  2022-09-07       Impact factor: 5.467

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.